Medical cannabis company IM Cannabis Corp. IMCC IMCC made its debut on the NASDAQ Capital Market on Monday becoming the first Israeli cannabis company to do so.
Shares experienced volatility on decent volume, closing the day up almost 5%. At the time of the writing of this article on Tuesday, shares were up by 8%.
In an email to Benzinga, IM Cannabis CEO Oren Shuster said he and his team are “extremely proud” to be the first Israeli medical cannabis operator to join the NASDAQ capital market “along with a select group of leading cannabis companies." He added:
“By joining NASDAQ, IMC provides American investors with access and a gateway to investments in the emerging European and Israeli cannabis markets where we have a strong presence and operations. Very few cannabis companies can boast having a decade-long experience in the medical cannabis space and we are leveraging this experience to further propel our international growth into additional high-potential markets."
Earlier this year, IM Cannabis entered the North American market through the acquisition of Canada-based Trichome Financial TFC and its adult-use cannabis operations.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.